176 related articles for article (PubMed ID: 11450615)
1. [Cytokine and anti-cytokine therapy in chronic inflammatory bowel diseases].
Wittig BM; Zeitz M
Dtsch Med Wochenschr; 2001 Jun; 126 Suppl 1():S52-8. PubMed ID: 11450615
[No Abstract] [Full Text] [Related]
2. [Chronic inflammatory bowel disease - new therapies: tumor necrosis factor-antibodies and cytokines].
Stange EF
Z Gastroenterol; 2002 Apr; 40 Suppl 1():S90-S1. PubMed ID: 11930299
[TBL] [Abstract][Full Text] [Related]
3. [Anti-cytokine therapy in inflammatory joint diseases].
Ehrenfeld M; Langevitz P; Shoenfeld Y
Harefuah; 1999 Aug; 137(3-4):120-4. PubMed ID: 10959300
[No Abstract] [Full Text] [Related]
4. [Monitoring of bioavailability, pharmacokinetics and immunogenicity of tumour necrosis factor-alpha inhibitors].
Steenholdt C; Ainsworth M; Thomsen OØ; Brynskov J; Bendtzen K
Ugeskr Laeger; 2010 Jan; 172(1):44-7. PubMed ID: 20056095
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms and efficacy of immunobiologic therapies for inflammatory bowel diseases.
Ghosh N; Chaki R; Mandal V; Lin GD; Mandal SC
Int Rev Immunol; 2010; 29(1):4-37. PubMed ID: 20100080
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor necrosis factor therapy for pediatric inflammatory bowel diseases.
Bujanover Y; Weiss B
Isr Med Assoc J; 2008; 10(8-9):634-9. PubMed ID: 18847168
[No Abstract] [Full Text] [Related]
7. [Chronic inflammatory bowel disease--pathogenic concepts and therapeutic perspectives].
Madsen JR
Ugeskr Laeger; 2000 Mar; 162(10):1361-6. PubMed ID: 10745672
[TBL] [Abstract][Full Text] [Related]
8. An immunomodulation strategy targeted towards immunocompetent cells or cytokines in inflammatory bowel diseases (IBD).
Heresbach D; Sémana G; Gosselin M; Bretagne MG
Eur Cytokine Netw; 1999 Mar; 10(1):7-15. PubMed ID: 10210767
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone in inflammatory bowel disease.
De Pascalis B; Bianchi A; Satta MA; Lupascu A; Mentella MC; Leo D; Fiore F; Fedeli P; Pontecorvi A; Pola P; Melina D; Gasbarrini A; De Marinis L; Armuzzi A
Eur Rev Med Pharmacol Sci; 2006; 10(1):13-6. PubMed ID: 16494105
[TBL] [Abstract][Full Text] [Related]
10. New therapies for inflammatory bowel disease: an update on chimeric anti-TNF alpha antibodies and IL-10 therapy.
van Hogezand RA; Verspaget HW
Scand J Gastroenterol Suppl; 1997; 223():105-7. PubMed ID: 9200315
[TBL] [Abstract][Full Text] [Related]
11. [Practical use of anti-TNF monoclonal antibodies in inflammatory bowel diseases].
Allez M
Gastroenterol Clin Biol; 2008 May; 32(5 Pt 1):467-77. PubMed ID: 18448294
[No Abstract] [Full Text] [Related]
12. Inflammatory bowel disease: short- and long-term treatments.
Bickston SJ; Cominelli F
Adv Intern Med; 1998; 43():143-74. PubMed ID: 9506181
[No Abstract] [Full Text] [Related]
13. Review article: Infliximab therapy for inflammatory bowel disease--seven years on.
Rutgeerts P; Van Assche G; Vermeire S
Aliment Pharmacol Ther; 2006 Feb; 23(4):451-63. PubMed ID: 16441465
[TBL] [Abstract][Full Text] [Related]
14. [Immunology in medical practice. IV. Inflammatory bowel diseases: pathogenic starting points for specific therapy].
van Deventer SJ
Ned Tijdschr Geneeskd; 1997 Oct; 141(41):1956-9. PubMed ID: 9550744
[TBL] [Abstract][Full Text] [Related]
15. Cytokine-based therapies for Crohn's disease--new paradigms.
Cominelli F
N Engl J Med; 2004 Nov; 351(20):2045-8. PubMed ID: 15537904
[No Abstract] [Full Text] [Related]
16. Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker.
Danese S
Dig Liver Dis; 2008 Jul; 40 Suppl 2():S225-8. PubMed ID: 18598993
[TBL] [Abstract][Full Text] [Related]
17. [Drug therapy of inflammatory bowel diseases].
Silvennoinen J; Niemelä S
Duodecim; 1999; 115(20):2233-8. PubMed ID: 11973927
[No Abstract] [Full Text] [Related]
18. [Practice guidelines in gastroenterology. Use of anti-TNF agents in inflammatory bowel disease. European guide 2001-2003].
Rom J Gastroenterol; 2002 Mar; 11(1):68-71. PubMed ID: 12219731
[No Abstract] [Full Text] [Related]
19. New cytokine therapeutics for inflammatory bowel disease.
Stokkers PC; Hommes DW
Cytokine; 2004 Nov 21-Dec 7; 28(4-5):167-73. PubMed ID: 15588691
[TBL] [Abstract][Full Text] [Related]
20. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor therapies. Foreword.
Magro F
BioDrugs; 2010 Dec; 24 Suppl 1():1-2. PubMed ID: 21175227
[No Abstract] [Full Text] [Related]
[Next] [New Search]
